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FoxOSteroid hormone and insulin/insulin-like growth factor signaling (IIS) pathways control development and
lifespan in the nematode Caenorhabditis elegans by regulating the activity of the nuclear receptor DAF-12 and
the FoxO transcription factor DAF-16, respectively. The DAF-12 ligands Δ4- and Δ7-dafachronic acid (DA)
promote bypass of the dauer diapause and proper gonadal migration during larval development; in adults,
DAs inﬂuence lifespan. Whether Δ4- and Δ7-DA have unique biological functions is not known. We identiﬁed
the 3-β-hydroxysteroid dehydrogenase (3βHSD) family member HSD-1, which participates in Δ4-DA
biosynthesis, as an inhibitor of DAF-16/FoxO activity. Whereas IIS promotes the cytoplasmic sequestration of
DAF-16/FoxO, HSD-1 inhibits nuclear DAF-16/FoxO activity without affecting DAF-16/FoxO subcellular
localization. Thus, HSD-1 and IIS inhibit DAF-16/FoxO activity via distinct and complementary mechanisms.
In adults, HSD-1 was required for full lifespan extension in IIS mutants, indicating that HSD-1 interactions
with IIS are context-dependent. In contrast to the Δ7-DA biosynthetic enzyme DAF-36, HSD-1 is dispensable
for proper gonadal migration and lifespan extension induced by germline ablation. These ﬁndings provide
insights into the molecular interface between DA and IIS pathways and suggest that Δ4- and Δ7-DA pathways
have unique as well as overlapping biological functions in the control of development and lifespan.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
In replete environments, Caenorhabditis elegans larvae undergo
four molts during reproductive development. When faced with
unfavorable conditions, they enter diapause, arresting in an alterna-
tive third larval stage known as dauer. Dauers are adapted for survival
and dispersal and resume development to adulthood once ambient
conditions improve (Riddle, 1988).
The elucidation of signal transduction pathways that regulate
dauer arrest has provided a glimpse into how organisms integrate
environmental cues with developmental programs. Genetic analysis
has deﬁned an intricate signaling network that controls the transition
to diapause (Fielenbach and Antebi, 2008; Hu, 2007). A pathway
regulated by the DAF-11 guanylyl cyclase (Birnby et al., 2000) acts in
sensory neurons to promote reproductive development by potenti-
ating the expression of insulin-like (Li et al., 2003; Pierce et al., 2001)
and transforming growth factor-beta (TGFβ)-like (Murakami et al.,
2001; Ren et al., 1996; Schackwitz et al., 1996) ligands. These ligandsregulate gene expression by activating conserved insulin-like and
TGFβ-like signal transduction pathways in target tissues.
A hormone biosynthetic pathway also regulates dauer arrest by
synthesizing dafachronic acids (DAs), which are steroid ligands for the
nuclear receptor DAF-12 (Motola et al., 2006). The cytochrome P450
DAF-9 (Gerisch et al., 2001; Jia et al., 2002) acts on distinct precursors
to generate two DAs, Δ4- and Δ7-DA (Motola et al., 2006). Precursors
for Δ4- and Δ7-DA are thought to be synthesized by the 3-β-
hydroxysteroid dehydrogenase (3βHSD) family member HSD-1
(Patel et al., 2008) and the Rieske oxygenase DAF-36 (Rottiers et al.,
2006), respectively (Fig. 1). DA binding to DAF-12 promotes
reproductive development, whereas unliganded DAF-12 promotes
dauer arrest (Motola et al., 2006). Although synthetic Δ7-DA is more
potent than synthetic Δ4-DA in dauer rescue bioassays (Sharma et al.,
2009), exogenous Δ4-DA rescues daf-36 mutant phenotypes (Gerisch
et al., 2007; Rottiers et al., 2006), indicating that Δ4-DA can
compensate for a reduction in Δ7-DA in vivo. Whether Δ4-DA and
Δ7-DA have distinct biological functions is not known.
daf-12 mutations suppress dauer arrest in daf-11 and daf-7/TGFβ
pathway mutants (Thomas et al., 1993), indicating that DAF-12 is
required for dauer arrest in thesemutants and suggesting that DAF-12
acts downstream of DAF-11 and DAF-7/TGFβ pathways. In contrast,
Fig. 1. Hypothetical model of dafachronic acid (DA) biosynthetic pathways.
Adapted from Rottiers et al. (2006) and Patel et al. (2008).
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way appears to be complex. Whereas reduced insulin-like signaling
results in constitutive dauer arrest, daf-12mutations cause a synthetic
non-dauer larval arrest phenotype in the context of reduced insulin-
like signaling (Larsen et al., 1995; Vowels and Thomas, 1992).
Furthermore, exogenous Δ4-DA fully rescues dauer arrest in daf-9
and daf-7/TGFβ mutants but causes non-dauer larval arrest in some
strains harboring mutations in the insulin receptor (InsR) ortholog
DAF-2 (Motola et al., 2006). The molecular basis for these interactions
between DA and insulin-like signaling remains poorly understood.
Upon engagement by insulin-like ligands, DAF-2/InsR promotes
reproductive development by activating a conserved phosphoinosi-
tide 3-kinase (PI3K)/Akt pathway (Morris et al., 1996; Paradis et al.,
1999; Paradis and Ruvkun, 1998). Dauer arrest caused by reductions
in DAF-2/InsR signaling is fully suppressed by mutations in the FoxO
transcription factor DAF-16 (Gottlieb and Ruvkun, 1994; Vowels and
Thomas, 1992), indicating that DAF-16/FoxO is the major target of
DAF-2/InsR pathway signaling and that DAF-2/InsR antagonizes DAF-
16/FoxO. DAF-2/InsR activation of PI3K/Akt signaling results in DAF-
16/FoxO phosphorylation by Akt and its subsequent cytoplasmic
sequestration via binding to 14-3-3 proteins (Berdichevsky et al.,
2006; Hertweck et al., 2004; Lee et al., 2001; Li et al., 2007; Lin et al.,
2001).
Although the inhibition of FoxO transcription factors by Akt in both
C. elegans and mammals is well established, multiple lines of evidence
support the existence of a second pathway that acts in parallel to
PI3K/Akt signaling to inhibit FoxO. DAF-16/FoxO that is constitutively
nuclear by virtue of either mutation of its consensus Akt/PKB
phosphorylation sites or inactivation of either AKT-1 or the 14-3-3protein FTT-2 is not fully active (Berdichevsky et al., 2006; Hertweck
et al., 2004; Lin et al., 2001; Zhang et al., 2008), suggesting that a
pathway acting in parallel to AKT-1 inhibits the activity of nuclear
DAF-16/FoxO. To identify components of this pathway, we performed
a genetic screen for enhancers of the dauer arrest phenotype seen in
akt-1 null mutants (eakmutants) (Hu et al., 2006; Zhang et al., 2008).
Here we report the cloning and characterization of eak-2. Surprisingly,
eak-2 is allelic to hsd-1 (Patel et al., 2008). This ﬁnding provided us
with an opportunity to examine the interface between C. elegans
insulin-like and DA pathways in dauer regulation and lifespan control.
Materials and methods
Strains
The following strains were used: N2 Bristol (wild-type), hsd-1
(mg345), hsd-1(mg433) (Patel et al., 2008), daf-9(k182) (Gerisch et al.,
2001), daf-36(k114) (Rottiers et al., 2006), glp-1(e2141) (Priess et al.,
1987), daf-16(mgDf47) (Ogg et al., 1997), daf-12(rh61rh411) (Antebi et
al., 2000), akt-1(mg306) (Hu et al., 2006), eak-3(mg344) (Zhang et al.,
2008), daf-2(e1370) (Kimura et al., 1997), sqt-1(sc13) age-1(hx546)
(Morris et al., 1996), pdk-1(sa709) (Paradis et al., 1999), eak-4(mg348)
(Hu et al., 2006), and sdf-9(mg337) (Hu et al., 2006). DAF-16::GFP
localization was assayed using strain TJ356 (zIs356) IV, which contains
an integrated C-terminal translational fusion of theDAF-16A isoform in-
frame to GFP (Henderson and Johnson, 2001). Strains CF1330 and
CF1371harborextrachromosomal arrays encodingwild-typeGFP::DAF-
16/FoxO and a constitutively nuclear GFP::DAF-16/FoxO mutant
lacking all AKT phosphorylation sites, respectively (Lin et al., 2001).
eak-2 mutant isolation, mapping, and sequencing
Isolation, mapping, and sequencing of eak-2 alleles were per-
formed as described for eak-3 (Zhang et al., 2008).
hsd-1 cDNA isolation
hsd-1 cDNA isolation was performed as described for eak-3 (Zhang
et al., 2008), except that total RNA was isolated from ﬂuorescent XXX
cells that had been FACS-puriﬁed from cultured embryonic cells
containing an integrated sdf-9p::RFP transgene (Hu et al., 2006).
hsd-1p::GFP construction and analysis
The hsd-1 promoter (corresponding to nucleotides 24,173–24,413 of
YAC Y6B3B, as annotated by the National Center for Biotechnology
Information, http://www.ncbi.nlm.nih.gov/)was ampliﬁed fromgeno-
mic DNA, a fragment containing GFP and the unc-54 3′ UTR was
ampliﬁed using pPD95.75 as a template, and the two PCRproductswere
fused using overlap extension PCR to create hsd-1p::GFP. hsd-1p::GFP
and the transformation marker plasmid pRF4 were coinjected at
concentrations of 40 ng/μl and 60 ng/μl respectively into animals con-
taining an integrated sdf-9p::RFP transgene. Transgenic animals were
generated, animals were visualized using an Olympus BX61 upright
microscope, and ﬂuorescence was analyzed using SlideBook 4.1 digital
microscopy software (Intelligent Imaging Innovations, Inc., Denver, CO,
USA) as described (Hu et al., 2006).
Gonadal migration assays
Egg lays were performed on standard NGM plates at 20 °C, and L4
larvae were scored for gonadal migration defects (Mig phenotype)
using a Nikon SMZ800 stereomicroscope. Mig phenotypes were con-
ﬁrmed by visualization on an Olympus BX61 upright microscope at
200× magniﬁcation.
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Lifespan assays were performed as described (Hu et al., 2006),
except that the 5-ﬂuorodeoxyuridine (FUDR) concentration used in
lifespan assays was 0.025 mg/ml. For lifespan assays on glp-1(e2141)
strains, animals were cultured at 25 °C after egg lay, and L4 animals
were picked to NGM plates containing nystatin but lacking FUDR and
incubated at 20 °C.
Dauer assays
Dauer assays were performed as described (Hu et al., 2006). To test
rescue of dauer arrest by various sterols, 10 μl of 100 μM sterol stock
solutionwasmixedwith 90 μl of concentrated E. coliOP50 suspension,
and the mix was aliquoted onto 6-cm NGM plates and allowed to dry
overnight at room temperature. These plates were then used for
standard dauer assays on hsd-1;akt-1 double mutant animals at 25 °C.
Final concentration of exogenous sterols was 111 nM. For assays of
strains harboring extrachromosomal DAF-16/FoxO transgenes, gravid
transgenic animals were picked for egg lays based on the Rol phe-
notype. Progeny were incubated at 25 °C and assayed for dauer arrest
48–60 h after egg lay. Animals that bypassed dauer arrest were scored
as Rol or non-Rol. Only Rol bypassors were included in calculations of
dauer arrest penetrance.
Quantitative real-time reverse transcriptase PCR (qPCR)
After a four-hour egg lay, animals were grown at 25 °C for 24 h prior
to harvesting. Total RNA isolation, cDNA synthesis, and quantitative
real-time reverse transcriptase PCRwere performed using gene-speciﬁc
primers as described (Zhang et al., 2008).
DAF-16::GFP localization
Animals harboring an integrated DAF-16::GFP transgene were
grown at 25 °C and analyzed as described (Zhang et al., 2008). To
obtain a distribution of DAF-16::GFP localization patterns in a
population of animals, single animals were categorized as exhibiting
nuclear, nuclear and cytoplasmic, or cytoplasmic ﬂuorescence, and
percentages of animals exhibiting each pattern were calculated for
each strain.
Results
Animals harboring the akt-1(mg306) null mutation arrest as
dauers at 27 °C but develop reproductively at 25 °C (Hu et al.,
2006). To identify mutations that enhance the akt-1(mg306) dauer
arrest phenotype, we mutagenized akt-1(mg306) animals and
screened for rare F2 dauers at 25 °C. After excluding mutants whose
dauer arrest phenotype was either not suppressed by daf-16/FoxO
RNAi or did not require the presence of the akt-1(mg306) mutation,
we identiﬁed 21 independent mutants that deﬁne seven eak genes.
Four eak genes have been cloned: eak-3, eak-4, sdf-9 (which is allelic
to eak-5), and eak-6. They encode plasma membrane-associated
proteins that function in a single pathway to promote reproductive
development by acting in parallel to AKT-1 to inhibit DAF-16/FoxO
activity nonautonomously (Hu et al., 2006; Zhang et al., 2008).
eak-2 is deﬁned by two independent alleles,mg334 andmg345. We
cloned eak-2 and found that it is allelic to the 3βHSD family member
hsd-1 (see Supplementary data for details), which was originally
identiﬁed in a screen for enhancers of the ncr-1 dauer arrest
phenotype (Patel et al., 2008). HSD-1 is thought to participate in the
biosynthesis of DAs. DAF-9, which is expressed in the XXX cells, the
hypodermis, and the hermaphrodite spermatheca (Gerisch et al.,
2001; Jia et al., 2002), catalyzes the ﬁnal steps in the biosynthesis of
two distinct DAs, Δ4-DA and Δ7-DA, from the precursors 4-cholesten-3-one and lathosterone (Motola et al., 2006) (Fig. 1). The predicted
biochemical activity of HSD-1 and the expression pattern of hsd-1p::
GFP (Fig. S3; (Patel et al., 2008) suggest that HSD-1 and DAF-9
participate in Δ4-DA biosynthesis in the XXX cells, whereas DAF-36
and hypodermal DAF-9 synthesize Δ7-DA (Fig. 1).
hsd-1 mutants undergo dauer arrest in a DAF-16/FoxO- and
DAF-12-dependent manner
hsd-1 single mutants do not have a strong dauer arrest phenotype
at 25 °C (Figs. 2B and C). However, they do undergo dauer arrest at
27 °C when cultured on NGM plates lacking supplemental cholesterol
(Fig. 2A). Dauer arrest in these conditions required both DAF-16/FoxO
and DAF-12, indicating that HSD-1 promotes reproductive develop-
ment by antagonizing DAF-16/FoxO and DAF-12. hsd-1mutation also
enhanced the dauer arrest phenotype of other DA biosynthetic
mutants (Fig. 2B). As previously shown (Patel et al., 2008), precursors
of both Δ4- and Δ7-DA rescued the hsd-1 dauer arrest phenotype
(Fig. S4).
Since hsd-1 mutations strongly enhance the dauer arrest pheno-
type of akt-1 mutants (Figs. 2B and C), we tested the interactions of
hsd-1 with other daf-2/InsR pathway mutants. hsd-1 mutations also
enhanced the dauer arrest phenotypes of age-1/PI3K and pdk-1
mutants, consistent with HSD-1 acting in parallel to the PI3K/Akt
pathway (Fig. 2C). The strong dauer arrest phenotype of hsd-1;akt-1
doublemutants also required both DAF-16/FoxO and DAF-12 function
(Fig. 2C). hsd-1mutation also enhanced the dauer arrest phenotype of
daf-2(e1370) mutants; whereas daf-2(e1370) animals develop repro-
ductively at 15 °C, a signiﬁcant fraction of hsd-1;daf-2 double mutant
animals arrested as dauers at 15 °C (Fig. 2D). daf-2mutants harboring
the hsd-1(mg433)molecular null mutation had a stronger dauer arrest
phenotype than daf-2mutants harboring the hsd-1(mg345) missense
mutation (Fig. 2D), suggesting that hsd-1(mg345) is a non-null allele.
Since HSD-1 likely functions in DA biosynthesis, we tested other
DA biosynthetic mutants for their ability to enhance the dauer arrest
phenotype of akt-1(mg306). The daf-9(k182) partial loss-of-function
mutation (Gerisch et al., 2001) also enhanced the dauer arrest
phenotype of akt-1 mutants (Fig. 2B). The daf-36 gene is located on
the same cosmid as akt-1, hindering the construction of a daf-36 akt-1
double mutant. However, we previously showed that RNAi of akt-1
enhances dauer arrest in a daf-36 mutant background (Zhang et al.,
2008). Thus, mutations predicted to reduce the synthesis of either Δ4-
or Δ7-DA or both DAs enhance the dauer arrest phenotype of akt-1
mutants. These ﬁndings indicate that DAs act in parallel to AKT-1 to
inhibit dauer arrest. Taken together with the observation that
precursors of both Δ4- and Δ7-DA rescue dauer arrest in hsd-1;akt-1
double mutants (Fig. S4), they suggest that Δ4- and Δ7-DA act
redundantly to promote reproductive development.
hsd-1 mutation did not enhance the dauer arrest phenotype of
other eak mutants (Figs. 2B and C), suggesting that HSD-1 and the
other EAK proteins act in the same pathway and in parallel to the
PI3K/Akt pathway in dauer regulation.
HSD-1 regulates DAF-16/FoxO target gene expression in a DAF-16/FoxO
and DAF-12-dependent manner
The requirement of DAF-16/FoxO for dauer arrest in hsd-1
mutants suggests that hsd-1 mutation increases DAF-16/FoxO
activity. To test this, we used quantitative real-time reverse
transcriptase PCR (qPCR) to measure endogenous mRNA levels of
three direct DAF-16/FoxO target genes: sod-3 (Oh et al., 2006), mtl-1
(Murphy et al., 2003), and dod-3 (Murphy et al., 2003) (Fig. 3). The
expression proﬁle across six strains was qualitatively similar for all
three DAF-16/FoxO target genes. hsd-1 mutation had modest effects
on transcript levels. As previously observed (Zhang et al., 2008), akt-1
mutation increased transcript levels of all three genes. This is
Fig. 2. HSD-1 regulation of dauer arrest. A. hsd-1(mg433) animals arrest as dauers at 27 °C on NGM plates lacking supplemental cholesterol in a DAF-16/FoxO- and DAF-12-
dependent manner. B. Synthetic dauer arrest phenotypes at 25 °C in combinations of hsd-1 and akt-1mutations withmutations in DA biosynthetic pathway components. C. The hsd-1
(mg433) mutation enhances dauer arrest at 25 °C in PI3K/Akt pathway mutants but not in other eak mutants. D. hsd-1 mutations enhance dauer arrest at 15 °C in daf-2(e1370)
mutants. Error bars: s.d.
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caused by reduction of AKT-1 activity (Hertweck et al., 2004; Zhang et
al., 2008). hsd-1 mutation synergized with akt-1 mutation to further
increase DAF-16/FoxO target gene expression. This increase required
both DAF-12 and DAF-16/FoxO activity, consistent withwhat we have
previously observed with eak-3 mutation (Zhang et al., 2008). Thus,
HSD-1 inhibits DAF-16/FoxO target gene expression in a DAF-12- and
DAF-16/FoxO-dependent manner, and both DAF-12 and DAF-16/
FoxO are required for maximal DAF-16/FoxO target gene expression
in hsd-1;akt-1 double mutants. Since DAF-16/FoxO activates sod-3
transcription directly (Oh et al., 2006), this result suggests that in this
context, DAF-12 acts either upstream of or in parallel to DAF-16/FoxO
to promote sod-3 expression.
HSD-1 inhibits nuclear DAF-16/FoxO activity without inﬂuencing
DAF-16/FoxO subcellular localization
To gain further insight into how HSD-1 regulates DAF-16/FoxO
activity, we examined the localization of a functional DAF-16::GFP
fusion protein (Henderson and Johnson, 2001) in wild-type, akt-1
mutant, and hsd-1 mutant animals (Fig. S5 and 4A). As previously
reported, most wild-type animals exhibited diffuse ﬂuorescence
corresponding to cytoplasmic localization (Fig. 4A; Henderson and
Johnson, 2001; Zhang et al., 2008). akt-1 mutation promoted nuclear
localization of DAF-16::GFP, as shown by the increase in percentage of
animals exhibiting nuclear or nuclear and cytoplasmic ﬂuorescence
compared to wild-type (two-sided T-test: p=0.017; Fig. 4A). In con-
trast, the distribution of DAF-16::GFP ﬂuorescence patterns in hsd-1
single mutants was indistinguishable from that of wild-type animals
(two-sided T-test: p=0.562; Fig. 4A). Thus, in contrast to AKT-1,
which inhibits DAF-16/FoxO by promoting its translocation from
the nucleus to the cytoplasm, HSD-1 inhibits DAF-16/FoxO activity
without inﬂuencing its subcellular localization. Multiple efforts toconstruct an hsd-1;akt-1 double mutant strain harboring DAF-16::GFP
were unsuccessful, preventing us from determining whether hsd-1
mutation promotes the nuclear localization of DAF-16::GFP in an akt-1
mutant background.
To directly test the hypothesis that HSD-1 inhibits nuclear DAF-
16/FoxO activity, we assayed the ability of hsd-1mutation to activate
a constitutively nuclear GFP::DAF-16 fusion protein that lacks all Akt
phosphorylation sites (DAF-16AM) (Lin et al., 2001). Transgenic ani-
mals expressing DAF-16AM exhibit constitutive nuclear ﬂuorescence
but do not arrest as dauers or live long (Lin et al., 2001), suggesting
that in wild-type animals, nuclear DAF-16/FoxO is inhibited by a
pathway that does not promote its relocalization to the cytoplasm.
As previously reported, DAF-16AM animals did not arrest as dauers
at 25 °C in a wild-type background (Fig. 4B). hsd-1 mutation strong-
ly enhanced the 25 °C dauer arrest phenotype of animals harboring
DAF-16AM but did not promote dauer arrest in animals harboring a
wild-type GFP::DAF-16 transgene (Fig. 4B). Thus, the effect of hsd-1
mutation on dauer arrest is greatly enhanced in contexts in which
DAF-16/FoxO is nuclear, strongly suggesting that HSD-1 inhibits
nuclear DAF-16/FoxO activity.
HSD-1 is required for lifespan extension in DAF-2/InsR mutants
To determine whether HSD-1 plays a role in lifespan control, we
assayed the lifespan of hsd-1 mutants (Fig. 5). The lifespans of hsd-1
single mutants were comparable to that of wild-type animals. We
previously showed that akt-1 mutants exhibit a slight increase in
mean and median lifespan (Hu et al., 2006; Zhang et al., 2008); upon
reduction of the FUDR concentration by 75%, we now observe sig-
niﬁcant lifespan extension in akt-1mutants compared to wild-type or
hsd-1 mutants (Fig. 5A; pb0.0001 by the log-rank test). Two inde-
pendent hsd-1 mutant alleles modestly suppressed the lifespan
extension of akt-1 mutants, and this was of borderline statistical
Fig. 4. HSD-1 inhibits nuclear DAF-16/FoxO activity without promoting its transloca-
tion from the nucleus to the cytoplasm. A. Percentage of animals exhibiting
cytoplasmic, nuclear and cytoplasmic, or nuclear DAF-16::GFP localization. Error
bars: s.d. N=62 (wild-type), 77 (akt-1(mg306)), and 62 (hsd-1(mg433)). B. The hsd-1
(mg433)mutation enhances dauer arrest at 25 °C in animals harboring a constitutively
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for akt-1 vs. hsd-1(mg433);akt-1). This result contrasts with the strong
enhancement of dauer arrest in akt-1 mutants by hsd-1 mutation
(Figs. 2B and C).
In light of the trend toward suppression of lifespan extension of
akt-1 mutants by hsd-1 mutation, we determined the effect of hsd-1
mutation on the lifespan of daf-2/InsR mutants. Surprisingly, hsd-1
mutation signiﬁcantly reduced the lifespan of daf-2(e1370) mutants
(Fig. 5B; pb0.0001). This effect is unlikely to be a consequence of
general frailty due to hsd-1 mutation, as hsd-1 single mutants have
lifespans that are comparable to wild-type (Figs. 5A and B). Thus,
although HSD-1 does not inﬂuence lifespan substantially in wild-type
animals, it is required for maximal lifespan extension when insulin-
like signaling is reduced. The suppression of daf-2(e1370) lifespan
extension by hsd-1 mutation contrasts with its enhancement of daf-2
(e1370) dauer arrest (Fig. 2D) and suggests that HSD-1 can either
antagonize or potentiate DAF-16/FoxO activity, depending upon the
biological context.
HSD-1 is not required for proper gonadal migration or lifespan extension
in animals lacking a germline
In addition to their dauer-constitutive phenotypes, daf-9 and daf-36
loss-of-function mutants and daf-12 ligand binding domain mutants
exhibit developmental abnormalities in gonadal migration (Mig
phenotype) (Antebi et al., 2000; Gerisch et al., 2001; Jia et al., 2002;Fig. 3. HSD-1 regulation of DAF-16/FoxO target gene expression. Quantiﬁcation of
endogenous transcripts corresponding to the DAF-16/FoxO target genes A. sod-3, B.mtl-1,
and C. dod-3 in various mutant strains. Error bars: s.d.
nuclear GFP::DAF-16/FoxO mutant lacking all Akt phosphorylation sites (DAF-16AM)
but not in animals harboring wild-type GFP::DAF-16. Error bars: s.d.Rottiers et al., 2006). In these mutants, the gonadal leader cells fail
to turn dorsally and continue to migrate away from the primordial
vulva (Fig. S6A). Since exogenous Δ4-DA rescues the Mig phenotype
of daf-9 mutants (Motola et al., 2006) and HSD-1 is thought to par-
ticipate in Δ4-DA biosynthesis (Patel et al., 2008), we examined hsd-1
mutant animals for theMig phenotype. Surprisingly, in contrast to daf-9
and daf-36 mutants, which exhibited high penetrance Mig phe-
notypes (Fig. 5C), hsd-1 null mutants did not have discernible go-
nadal migration abnormalities (Figs. S6B and 5C). Thus, unlike DAF-9
and DAF-36, HSD-1 is not required for proper gonadal migration during
larval development.
DAF-9, DAF-36, and DAF-12 are also required for lifespan ex-
tension in animals lacking a germline (Berman and Kenyon, 2006;
Rottiers et al., 2006). Since HSD-1 is required for full lifespan ex-
tension in daf-2(e1370) mutant animals (Fig. 5B), we tested the role
of HSD-1 in lifespan extension caused by germline ablation. As pre-
viously shown (Rottiers et al., 2006), DAF-36was required for lifespan
extension in glp-1(e2141) mutants lacking a germline (Fig. 5D). In
contrast, HSD-1 was completely dispensable for lifespan extension in
glp-1mutants. Thus, whereas HSD-1 and DAF-36 play similar roles in
dauer regulation (Fig. 2B), they have distinct functions in the control
of gonadal migration and lifespan.
Discussion
We have shown that the 3βHSD family member HSD-1 acts in par-
allel to AKT-1 to regulate dauer arrest via DAF-16/FoxO and DAF-12.
This is supported by three major lines of evidence. First, hsd-1
mutation strongly enhances the dauer arrest phenotype of an akt-1
null mutant in a DAF-16/FoxO- and DAF-12-dependent manner
(Fig. 2C). hsd-1 mutation also synergizes with akt-1 mutation to en-
hance expression of the DAF-16/FoxO target gene sod-3 in a DAF-16/
FoxO- and DAF-12-dependent manner (Fig. 3A). Finally, hsd-1 mu-
tation enhances dauer arrest in animals expressing a constitutively
nuclear DAF-16/FoxO mutant that lacks all Akt phosphorylation sites
(Fig. 4B). The observations that daf-9 mutation also enhances dauer
arrest in an akt-1 null mutant (Fig. 2B) and that akt-1 RNAi induces
Fig. 5. Impact of hsd-1 mutation on lifespan and gonadal migration. A. Effect of hsd-1 mutations on lifespan at 20 °C in various genetic backgrounds. B. Effect of the hsd-1(mg433)
mutation on lifespan extension in daf-2(e1370) mutants at 20 °C. C. Percentage of wild-type and mutant populations exhibiting the Mig phenotype at 20 °C. Error bars: s.d.
D. Lifespan extension in glp-1(e2141) mutant animals does not require hsd-1.
610 K.J. Dumas et al. / Developmental Biology 340 (2010) 605–612dauer arrest and DAF-16/FoxO target gene expression in a daf-36
mutant (Zhang et al., 2008) are consistent with the postulated role of
HSD-1 in synthesizing the Δ4-DA precursor 4-cholesten-3-one (Patel
et al., 2008) (Fig. 1). Taken together, these data suggest that DAs act in
parallel to AKT-1 to promote reproductive development via DAF-16/
FoxO and DAF-12.
Based on their observation that DAF-16::GFP localizes to the
nucleus in hsd-1;ncr-1 double mutants, Patel et al. (2008) have
proposed that steroid signaling promotes reproductive development
by inhibiting DAF-16/FoxO nuclear localization. However, they did
not address the question of how HSD-1 itself regulates DAF-16/FoxO
activity. We ﬁnd that, in contrast to akt-1 mutation, which promotes
the translocation of a functional DAF-16::GFP fusion protein from the
cytoplasm to the nucleus, hsd-1mutation does not inﬂuence DAF-16::
GFP localization (Fig. 4A). Furthermore, hsd-1 mutation strongly
promotes dauer arrest in animals expressing a constitutively nuclear
DAF-16/FoxO mutant that lacks all of its Akt phosphorylation sites
while having no effect on animals expressing wild-type DAF-16/FoxO
(Fig. 4B). HSD-1 also acts in the same dauer regulatory pathway asFig. 6. Hypothetical models of insulin-like and DA pathways in the control of diapause, lon
pathways to promote reproductive development. B. HSD-1 does not participate in lifespan co
insulin-like signaling. C. Regulation of gonadal migration does not require HSD-1.other EAK proteins (Figs. 2B and C), none of which inﬂuences DAF-16/
FoxO localization (Zhang et al., 2008). Based on these data, we favor
a model whereby HSD-1 inhibits the activity of nuclear-localized
DAF-16/FoxO without promoting its translocation from the nucleus
to the cytoplasm. It is possible that hsd-1mutation has indirect effects
on other signaling pathways that may promote DAF-16/FoxO nuclear
translocation in an ncr-1 mutant background (Patel et al., 2008).
Surprisingly, whereas hsd-1 mutation enhanced the dauer arrest
phenotype of DAF-2/InsR pathway mutants, including daf-2(e1370)
(Figs. 2B–D), it suppressed the lifespan extension phenotype of daf-2
(e1370) (Fig. 5B). Thus, HSD-1 can either potentiate or antagonize
DAF-2/InsR signaling depending upon the biological context (Fig. 6).
This could be due to context-dependent effects of the Δ4-DA/DAF-12
interaction, the interaction of Δ4-DA with nuclear receptors other
than DAF-12 during adulthood, or a possible role for HSD-1 in the
biosynthesis of distinct steroid hormones during larval development
and adulthood.
Whereas mutations in hsd-1 and daf-36 have similar effects on
dauer arrest (Fig. 2B; Rottiers et al., 2006), they differ in their impactgevity, and gonadal migration. A. HSD-1 and DAF-36 act in canonical DA biosynthetic
ntrol by the germline pathway but promotes lifespan extension in animals with reduced
611K.J. Dumas et al. / Developmental Biology 340 (2010) 605–612on lifespan extension and gonadal migration (Figs. 5C, D, and S6;
Antebi et al., 2000; Gerisch et al., 2001; Rottiers et al., 2006). In
contrast to daf-36 mutation, hsd-1 mutation does not cause defects
in gonadal migration and does not suppress lifespan extension caused
by germline ablation (Figs. 5C and D). Thus, Δ4- and Δ7-DA pathways
may have overlapping and distinct functions in the control of de-
velopment and lifespan. Since HSD-1 is the only putative DA bio-
synthetic enzyme that is speciﬁcally expressed in the XXX cells
(Fig. S3; Gerisch et al., 2001; Patel et al., 2008; Rottiers et al., 2006),
this result suggests that Δ4-DA synthesized in the XXX cells does
not inﬂuence gonadal migration or lifespan in the context of germline
ablation. This could be due to the presence of DAs synthesized in other
tissues that sufﬁce to promote normal gonadal migration in hsd-1
mutants and lifespan extension in hsd-1;glp-1 double mutants.
Indeed, the ability of exogenous Δ4-DA to rescue both the gonadal
migration phenotype as well as the suppression of glp-1(e2141)
lifespan extension caused by daf-9 mutation (Gerisch et al., 2007;
Motola et al., 2006) indicates that Δ4-DA can regulate these processes.
However, the partial suppression of lifespan extension in daf-2
(e1370) mutants by hsd-1 mutation suggests that other DAs that
may compensate for loss of HSD-1 activity to promote normal gonadal
migration and lifespan in germline-ablated animals are not sufﬁcient
to do so in the context of reduced insulin-like signaling.
In aggregate, our data support distinct roles for DA pathways in
dauer regulation, the control of lifespan, and gonadal migration
(Fig. 6). In dauer regulation, HSD-1 and DAF-36 act in parallel to AKT-
1 to promote reproductive development via DAF-12 and DAF-16/
FoxO (Fig. 6A). During adulthood, DAF-36 is required for lifespan
extension in animals lacking a germline. In contrast, HSD-1 is
dispensable for lifespan extension caused by germline ablation but
required for lifespan extension in animals with reduced insulin-like
signaling (Fig. 6B). HSD-1 has no apparent role in the regulation of
gonadal migration by DAs (Fig. 6C). Since neither the biochemical
activities of HSD-1 and DAF-36 nor the steroid proﬁles of hsd-1 and
daf-36 mutants have been characterized, the caveat must be
considered that differences in levels of and/or the anatomical site of
DA synthesis could contribute to differences in hsd-1 and daf-36
mutant phenotypes.
Ourmodel of HSD-1 as a regulator of nuclear DAF-16/FoxO activity
suggests that human SDR42E1, the putative HSD-1 ortholog, could
play an important role in the regulation of FoxO transcription factor
activity in physiological or pathophysiological states in which PI3K/
Akt pathway activity is low. For example, FoxO1 localizes to hepa-
tocyte nuclei in fasted wild-type as well as diabetic mice (Aoyama
et al., 2006). In light of recent reports highlighting the role of hepatic
FoxO1 in glucose homeostasis (Dong et al., 2008; Matsumoto et al.,
2007), SDR42E1 could be a critical regulator of nuclear FoxO1 activity
and glucose metabolism in the liver. FoxO1 also localizes to the
nucleus in response to dietary restriction in tumors lacking activating
PI3K/Akt pathway mutations, and FoxO1 overexpression sensitizes
such tumors to dietary-restriction-induced apoptosis (Kalaany and
Sabatini, 2009); in this context, SDR42E1 could modulate the apo-
ptotic response of tumors to dietary restriction. Finally, the association
of FoxO3 polymorphisms with extreme human longevity (Flachsbart
et al., 2009; Willcox et al., 2008) suggests the possibility that HSD-1
control of lifespan may also be phylogenetically conserved.
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